1. Cell Cycle/DNA Damage Vitamin D Related/Nuclear Receptor Metabolic Enzyme/Protease
  2. PPAR
  3. PPARα/γ agonist 4

PPARα/γ agonist 4 (Compound (S)-7) 是具口服有效性的 PPARαPPARγ 的双重强效激活剂,EC50 值分别为 0.061 μM 和 1.42 μM。PPARα/γ agonist 4 通过胰岛素非依赖性机制起作用,具有线粒体丙酮酸载体抑制和抗糖尿病特性。PPARα/γ agonist 4 有望用于血脂异常型 2 型糖尿病领域研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

PPARα/γ agonist 4 Chemical Structure

PPARα/γ agonist 4 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 PPAR 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

PPARα/γ agonist 4 (Compound (S)-7) is an orally active dual potent agonist of PPARα and PPARγ, with EC50 values of 0.061 μM and 1.42 μM respectively. PPARα/γ agonist 4 acts through an insulin-independent mechanism and exhibits mitochondrial pyruvate carrier inhibition and anti-diabetic properties. PPARα/γ agonist 4 is expected to be used in research for dyslipidemic type 2 diabetes[1].

IC50 & Target[1]

PPARα

 

PPAR-γ

 

体外研究
(In Vitro)

PPARα/γ agonist 4 (100 nM, 24 小时) 能够增加 C2C12 细胞系的葡萄糖的摄取和代谢,并通过增强脂肪酸降解的线粒体活性避免肝细胞或肌肉细胞中的脂质积累[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

PPARα/γ agonist 4 (25 mg/kg, 50 mg/kg, 口服, 治疗15天) 在糖尿病小鼠模型中以剂量依赖方式发挥抗高血糖作用,同时具有显著降脂功效[1]

药代动力学分析[1]

PPARα/γ agonist 4 Does Volume (mL/kg) C0/Cmax(ng/mL) Tmax (h) AUClast(h·ng/mL) AUCinfinity (h⋅ng/mL) T1/2 (h) Vd (L/kg) CL (mL/min/kg) MRTlast(h) F (%)
i.v. (1 mg/kg) 10 2300 0.083 11400 11800 4.74 0.581 1.42 6.04 -
p.o. (5 mg/kg) 10 4280 2 43600 49000 7.61 1.16 1.74 7.74 76.4

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Streptozotocin (HY-13753) -induced diabetic mouse model[1]
Dosage: 25 mg/kg, 50 mg/kg
Administration: Oral gavage (p.o.), 15 days
Result: At a dose of 50 mg/kg exhibited greater hypoglycemic effects compared to the 25 mg/kg dose.
Oral treatment with PPARα/γ agonist 4 at 25 mg/kg significantly reduced levels of total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides.
The 50 mg/kg dose reduced total cholesterol and HDL-C levels, but showed a smaller improvement in triglyceride levels.
分子量

368.42

Formula

C25H20O3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
PPARα/γ agonist 4
目录号:
HY-162578
需求量: